Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

2.40p
   
  • Change Today:
      0.12p
  • 52 Week High: 5.90
  • 52 Week Low: 1.09
  • Currency: UK Pounds
  • Shares Issued: 499.72m
  • Volume: 1,351,173
  • Market Cap: £11.97m
  • RiskGrade: 328

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Timothy Paul McCarthy 1,488,462 £35,649
Lisa Baderoon 583,963 £13,986
Tim Franklin 525,000 £12,574

Major Shareholders

Notifier** Holding Value*
Lanstead Capital LP 64,932,129 £1,555,124
Luca & Associates AG 22,000,000 £526,900
Invesco Ltd 17,872,341 £428,043
Aviva Investors Global 11,285,180 £270,280
Alora Pharmaceuticals LLC 10,909,091 £261,273
M&G Investments 7,600,000 £182,020
Prudential plc 7,600,000 £182,020
Capital Income Builder 4,870,367 £116,645
Dr R Zimmer 4,551,553 £109,010
Odey Asset Management 3,433,319 £82,228
Rhone Trustees (Switzerland) SA 3,386,000 £81,095
Pictet Overseas Trust Corporation Limited 3,287,500 £78,736

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 2.40p
Change Today 0.12p
% Change 5.04 %
52 Week High 5.90
52 Week Low 1.09
Volume 1,351,173
Shares Issued 499.72m
Market Cap £11.97m
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
28.96% below the market average28.96% below the market average28.96% below the market average28.96% below the market average28.96% below the market average
8.70% above the sector average8.70% above the sector average8.70% above the sector average8.70% above the sector average8.70% above the sector average
Price Trend
44.99% above the market average44.99% above the market average44.99% above the market average44.99% above the market average44.99% above the market average
69.57% above the sector average69.57% above the sector average69.57% above the sector average69.57% above the sector average69.57% above the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 20-Jun-2025

Time Volume / Share Price
15:26 20,000 @ 2.33p
15:19 4,627 @ 2.49p
15:12 114,357 @ 2.40p
14:58 10,278 @ 2.39p
14:51 1,515 @ 2.39p

Immupharma Key Personnel

CEO Timothy Paul McCarthy

Top of Page